Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Facial WastingFacial Wasting
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Drug resistance and lypodystrophy
Jan 20, 2005

With resistance to combivir and stoctrin, my doctor put me on a viracept, Norvir, videx and zerit combination. So far it has been okay except for a very low cd4 which is not improving (107). However, I have started experiencing lypoastrophy/dystrophy, loosing fat in limbs, face and buttocks. I wonder if fuzeon has a propensity to cause lypo?

Response from Mr. Kurtyka

I am not aware of any data that indicates that Fuzeon directly contributes to lipoatrophy/lipodystrophy. The group of drugs most commonly believed to be involved in the lipoatrophy process are the nucleoside reverse transcriptase inhibitors (NRTIs), most notably stavudine (Zerit). In looking at your antiretroviral regimen, I suspect the Zerit and Videx are probably contributing most to your lipoatrophy.

--dk



Previous
?Immunocompromised?
Next
Fuzeon Injection Sites

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement